Structure of a Eukaryotic CRISPR-Cas homolog, Fanzor2, Shows Its Promise for Gene Editing

Credit: St. Jude Children's Research Hospital

Elizabeth Kellogg, PhD, St. Jude Department of Structural Biology, used cryo-EM to study the evolutionary journey of Fanzor2, a compact eukaryotic genome-editing protein with huge potential.

« Structure of a Eukaryotic CRISPR-Cas homolog, Fanzor2, Shows Its Promise for Gene Editing

Expert Pitch

Expert Query

Expert Directory